Evidence map›Paper›PMID 30619245›Full record

ArticleFrontiers in immunology2018

A Novel Approach of Identifying Immunodominant Self and Viral Antigen Cross-Reactive T Cells and Defining the Epitopes They Recognize.

Junbao Yang, Lichen Jing, Eddie A James, John A Gebe, David M Koelle, William W Kwok

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Junbao YangBenaroya Research Institute at Virginia Mason, Seattle, WA, United States.
Lichen JingDepartment of Medicine, University of Washington, Seattle, WA, United States.
Eddie A JamesBenaroya Research Institute at Virginia Mason, Seattle, WA, United States.
John A GebeBenaroya Research Institute at Virginia Mason, Seattle, WA, United States.
David M KoelleBenaroya Research Institute at Virginia Mason, Seattle, WA, United States.
William W KwokBenaroya Research Institute at Virginia Mason, Seattle, WA, United States.
Benaroya Research InstituteVirginia Mason Medical Center · USUniversity of Washington · US

Funding

Mechanisms for HLA-DQ mediated disease protection and susceptibilityDP3DK097653 · NIDDK · BENAROYA RESEARCH INST AT VIRGINIA MASON · PI KWOK, WILLIAM W. · 2012 to 2012
$3.5M
Phenotypic Analysis of Islet Antigen-specific Effector T Cells in Pre-diabetic SubjectsDP3DK106909 · NIDDK · BENAROYA RESEARCH INST AT VIRGINIA MASON · PI KWOK, WILLIAM W. · 2015 to 2015
$2.2M
NIDDK NIH HHS DP3 DK097653NIDDK NIH HHS DP3 DK106909
6 · The paper itself

Abstract

Infection and vaccination can lead to activation of autoreactive T cells, including the activation of cross-reactive T cells. However, detecting these cross-reactive T cells and identifying the non-self and self-antigen epitopes is difficult. The current study demonstrates the utility of a novel approach that effectively accomplishes both. We utilized surface expression of CD38 on newly activated CD4 memory T cells as a strategy to identify type 1 diabetes associated autoreactive T cells activated by influenza vaccination in healthy subjects. We identified an influenza A matrix protein (MP) specific CD4+ T cell clone that cross-recognizes an immunodominant epitope from Glutamic Acid Decarboxylase 65 (GAD65) protein. The sequences of the MP and GAD65 peptides are rather distinct, with only 2 identical amino acids within the HLA-DR binding region. This result suggests that activation of autoreactive T cells by microbial infection under certain physiological conditions can occur amongst peptides with minimum amino acid sequence homology. This novel strategy also provides a new research pathway in which to examine activation of autoreactive CD4+ T cells after vaccination or natural infection.

Indexed as

ADP-ribosyl Cyclase 1Amino Acid SequenceAntigens, ViralCD4-Positive T-LymphocytesCross ReactionsDiabetes Mellitus, Type 1Epitopes, T-LymphocyteGlutamate DecarboxylaseHLA-DR AntigensHumansImmunodominant EpitopesInfluenza A virusInfluenza, HumanInfluenza VaccinesPeptidesADP-ribosyl Cyclase 1Antigens, ViralEpitopes, T-LymphocyteGlutamate Decarboxylaseglutamate decarboxylase 2HLA-DR AntigensImmunodominant EpitopesInfluenza VaccinesPeptidesautoreactive T cellsglutamate decarboxylase 65influenzamolecular mimicryT cell cross-reactivity

Identifiers

PMID30619245
PMCPMC6298415
OpenAlexW2904089069

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.